Application Sponsors
ANDA 216953 | APTAPHARMA INC | |
Marketing Status
Application Products
001 | SOLUTION;ORAL | EQ 20MG BASE/5ML | 0 | FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-11-15 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
APTAPHARMA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 216953
[companyName] => APTAPHARMA INC
[docInserts] => ["",""]
[products] => [{"drugName":"FLUOXETINE HYDROCHLORIDE","activeIngredients":"FLUOXETINE HYDROCHLORIDE","strength":"EQ 20MG BASE\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/15\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-11-15
)
)